世界の小児用ワクチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Paediatric Vaccine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4404 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、小児用ワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（肺炎球菌、水痘、混合、ポリオウイルス、肝炎、MMR、小児ホルモン、HIB、アレルギー＆呼吸器ワクチン、その他）、用途別市場規模（0～3、3～12、12歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・小児用ワクチンの市場動向 ・企業の競争状況、市場シェア ・小児用ワクチンの種類別市場規模（肺炎球菌、水痘、混合、ポリオウイルス、肝炎、MMR、小児ホルモン、HIB、アレルギー＆呼吸器ワクチン、その他） ・小児用ワクチンの用途別市場規模（0～3、3～12、12歳以上） ・小児用ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・小児用ワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・小児用ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小児用ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・小児用ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithCline、Merck、Sanofi、Bristol-Myers Squibb、Abbott Laboratories、Eli Lilly、Pfizer、F. Hoffmann-La Roche、Novo Nordisk） ・結論

Market Analysis and Insights: Global Paediatric Vaccine Market
The global Paediatric Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paediatric Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paediatric Vaccine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paediatric Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paediatric Vaccine market.

Global Paediatric Vaccine Scope and Market Size
Paediatric Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paediatric Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines

Segment by Application
Age (0-3)
Age (3-12)
Age Above 12

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pneumococcal
1.2.3 Varicella
1.2.4 Combinations
1.2.5 Poliovirus
1.2.6 Hepatitis
1.2.7 MMR
1.2.8 Pediatric Hormones
1.2.9 HIB
1.2.10 Allergy and Respiratory vaccines
1.2.11 Other Pediatric vaccines
1.3 Market by Application
1.3.1 Global Paediatric Vaccine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Age (0-3)
1.3.3 Age (3-12)
1.3.4 Age Above 12
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Paediatric Vaccine Market Perspective (2016-2027)
2.2 Paediatric Vaccine Growth Trends by Regions
2.2.1 Paediatric Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paediatric Vaccine Historic Market Share by Regions (2016-2021)
2.2.3 Paediatric Vaccine Forecasted Market Size by Regions (2022-2027)
2.3 Paediatric Vaccine Industry Dynamic
2.3.1 Paediatric Vaccine Market Trends
2.3.2 Paediatric Vaccine Market Drivers
2.3.3 Paediatric Vaccine Market Challenges
2.3.4 Paediatric Vaccine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Paediatric Vaccine Players by Revenue
3.1.1 Global Top Paediatric Vaccine Players by Revenue (2016-2021)
3.1.2 Global Paediatric Vaccine Revenue Market Share by Players (2016-2021)
3.2 Global Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paediatric Vaccine Revenue
3.4 Global Paediatric Vaccine Market Concentration Ratio
3.4.1 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Vaccine Revenue in 2020
3.5 Paediatric Vaccine Key Players Head office and Area Served
3.6 Key Players Paediatric Vaccine Product Solution and Service
3.7 Date of Enter into Paediatric Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Paediatric Vaccine Breakdown Data by Type
4.1 Global Paediatric Vaccine Historic Market Size by Type (2016-2021)
4.2 Global Paediatric Vaccine Forecasted Market Size by Type (2022-2027)

5 Paediatric Vaccine Breakdown Data by Application
5.1 Global Paediatric Vaccine Historic Market Size by Application (2016-2021)
5.2 Global Paediatric Vaccine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Paediatric Vaccine Market Size (2016-2027)
6.2 North America Paediatric Vaccine Market Size by Type
6.2.1 North America Paediatric Vaccine Market Size by Type (2016-2021)
6.2.2 North America Paediatric Vaccine Market Size by Type (2022-2027)
6.2.3 North America Paediatric Vaccine Market Size by Type (2016-2027)
6.3 North America Paediatric Vaccine Market Size by Application
6.3.1 North America Paediatric Vaccine Market Size by Application (2016-2021)
6.3.2 North America Paediatric Vaccine Market Size by Application (2022-2027)
6.3.3 North America Paediatric Vaccine Market Size by Application (2016-2027)
6.4 North America Paediatric Vaccine Market Size by Country
6.4.1 North America Paediatric Vaccine Market Size by Country (2016-2021)
6.4.2 North America Paediatric Vaccine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Paediatric Vaccine Market Size (2016-2027)
7.2 Europe Paediatric Vaccine Market Size by Type
7.2.1 Europe Paediatric Vaccine Market Size by Type (2016-2021)
7.2.2 Europe Paediatric Vaccine Market Size by Type (2022-2027)
7.2.3 Europe Paediatric Vaccine Market Size by Type (2016-2027)
7.3 Europe Paediatric Vaccine Market Size by Application
7.3.1 Europe Paediatric Vaccine Market Size by Application (2016-2021)
7.3.2 Europe Paediatric Vaccine Market Size by Application (2022-2027)
7.3.3 Europe Paediatric Vaccine Market Size by Application (2016-2027)
7.4 Europe Paediatric Vaccine Market Size by Country
7.4.1 Europe Paediatric Vaccine Market Size by Country (2016-2021)
7.4.2 Europe Paediatric Vaccine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Paediatric Vaccine Market Size (2016-2027)
8.2 Asia-Pacific Paediatric Vaccine Market Size by Type
8.2.1 Asia-Pacific Paediatric Vaccine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paediatric Vaccine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paediatric Vaccine Market Size by Type (2016-2027)
8.3 Asia-Pacific Paediatric Vaccine Market Size by Application
8.3.1 Asia-Pacific Paediatric Vaccine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paediatric Vaccine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paediatric Vaccine Market Size by Application (2016-2027)
8.4 Asia-Pacific Paediatric Vaccine Market Size by Region
8.4.1 Asia-Pacific Paediatric Vaccine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paediatric Vaccine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Paediatric Vaccine Market Size (2016-2027)
9.2 Latin America Paediatric Vaccine Market Size by Type
9.2.1 Latin America Paediatric Vaccine Market Size by Type (2016-2021)
9.2.2 Latin America Paediatric Vaccine Market Size by Type (2022-2027)
9.2.3 Latin America Paediatric Vaccine Market Size by Type (2016-2027)
9.3 Latin America Paediatric Vaccine Market Size by Application
9.3.1 Latin America Paediatric Vaccine Market Size by Application (2016-2021)
9.3.2 Latin America Paediatric Vaccine Market Size by Application (2022-2027)
9.3.3 Latin America Paediatric Vaccine Market Size by Application (2016-2027)
9.4 Latin America Paediatric Vaccine Market Size by Country
9.4.1 Latin America Paediatric Vaccine Market Size by Country (2016-2021)
9.4.2 Latin America Paediatric Vaccine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Paediatric Vaccine Market Size (2016-2027)
10.2 Middle East & Africa Paediatric Vaccine Market Size by Type
10.2.1 Middle East & Africa Paediatric Vaccine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paediatric Vaccine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paediatric Vaccine Market Size by Type (2016-2027)
10.3 Middle East & Africa Paediatric Vaccine Market Size by Application
10.3.1 Middle East & Africa Paediatric Vaccine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paediatric Vaccine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paediatric Vaccine Market Size by Application (2016-2027)
10.4 Middle East & Africa Paediatric Vaccine Market Size by Country
10.4.1 Middle East & Africa Paediatric Vaccine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paediatric Vaccine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Details
11.1.2 GlaxoSmithCline Business Overview
11.1.3 GlaxoSmithCline Paediatric Vaccine Introduction
11.1.4 GlaxoSmithCline Revenue in Paediatric Vaccine Business (2016-2021)
11.1.5 GlaxoSmithCline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Paediatric Vaccine Introduction
11.2.4 Merck Revenue in Paediatric Vaccine Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Paediatric Vaccine Introduction
11.3.4 Sanofi Revenue in Paediatric Vaccine Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Paediatric Vaccine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Paediatric Vaccine Introduction
11.5.4 Abbott Laboratories Revenue in Paediatric Vaccine Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Paediatric Vaccine Introduction
11.6.4 Eli Lilly Revenue in Paediatric Vaccine Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Paediatric Vaccine Introduction
11.7.4 Pfizer Revenue in Paediatric Vaccine Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Paediatric Vaccine Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2016-2021)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Paediatric Vaccine Introduction
11.9.4 Novo Nordisk Revenue in Paediatric Vaccine Business (2016-2021)
11.9.5 Novo Nordisk Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Paediatric Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pneumococcal
Table 3. Key Players of Varicella
Table 4. Key Players of Combinations
Table 5. Key Players of Poliovirus
Table 6. Key Players of Hepatitis
Table 7. Key Players of MMR
Table 8. Key Players of Pediatric Hormones
Table 9. Key Players of HIB
Table 10. Key Players of Allergy and Respiratory vaccines
Table 11. Key Players of Other Pediatric vaccines
Table 12. Global Paediatric Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Paediatric Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Paediatric Vaccine Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Paediatric Vaccine Market Share by Regions (2016-2021)
Table 16. Global Paediatric Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Paediatric Vaccine Market Share by Regions (2022-2027)
Table 18. Paediatric Vaccine Market Trends
Table 19. Paediatric Vaccine Market Drivers
Table 20. Paediatric Vaccine Market Challenges
Table 21. Paediatric Vaccine Market Restraints
Table 22. Global Paediatric Vaccine Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Paediatric Vaccine Market Share by Players (2016-2021)
Table 24. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Vaccine as of 2020)
Table 25. Ranking of Global Top Paediatric Vaccine Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Paediatric Vaccine Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Paediatric Vaccine Product Solution and Service
Table 29. Date of Enter into Paediatric Vaccine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Paediatric Vaccine Revenue Market Share by Type (2016-2021)
Table 33. Global Paediatric Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Paediatric Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Paediatric Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Paediatric Vaccine Revenue Market Share by Application (2016-2021)
Table 37. Global Paediatric Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Paediatric Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Paediatric Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Paediatric Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Paediatric Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Paediatric Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Paediatric Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Paediatric Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Paediatric Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Paediatric Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Paediatric Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Paediatric Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Paediatric Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Paediatric Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Paediatric Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Paediatric Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Paediatric Vaccine Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Paediatric Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Paediatric Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Paediatric Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Paediatric Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Paediatric Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Paediatric Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Paediatric Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Paediatric Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Paediatric Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Paediatric Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Paediatric Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 69. GlaxoSmithCline Company Details
Table 70. GlaxoSmithCline Business Overview
Table 71. GlaxoSmithCline Paediatric Vaccine Product
Table 72. GlaxoSmithCline Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithCline Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Paediatric Vaccine Product
Table 77. Merck Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Paediatric Vaccine Product
Table 82. Sanofi Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Paediatric Vaccine Product
Table 87. Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Paediatric Vaccine Product
Table 92. Abbott Laboratories Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 93. Abbott Laboratories Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Paediatric Vaccine Product
Table 97. Eli Lilly Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Paediatric Vaccine Product
Table 102. Pfizer Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. F. Hoffmann-La Roche Company Details
Table 105. F. Hoffmann-La Roche Business Overview
Table 106. F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 107. F. Hoffmann-La Roche Recent Development
Table 108. Novo Nordisk Company Details
Table 109. Novo Nordisk Business Overview
Table 110. Novo Nordisk Paediatric Vaccine Product
Table 111. Novo Nordisk Revenue in Paediatric Vaccine Business (2016-2021) & (US$ Million)
Table 112. Novo Nordisk Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paediatric Vaccine Market Share by Type: 2020 VS 2027
Figure 2. Pneumococcal Features
Figure 3. Varicella Features
Figure 4. Combinations Features
Figure 5. Poliovirus Features
Figure 6. Hepatitis Features
Figure 7. MMR Features
Figure 8. Pediatric Hormones Features
Figure 9. HIB Features
Figure 10. Allergy and Respiratory vaccines Features
Figure 11. Other Pediatric vaccines Features
Figure 12. Global Paediatric Vaccine Market Share by Application: 2020 VS 2027
Figure 13. Age (0-3) Case Studies
Figure 14. Age (3-12) Case Studies
Figure 15. Age Above 12 Case Studies
Figure 16. Paediatric Vaccine Report Years Considered
Figure 17. Global Paediatric Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Paediatric Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Paediatric Vaccine Market Share by Regions: 2020 VS 2027
Figure 20. Global Paediatric Vaccine Market Share by Regions (2022-2027)
Figure 21. Global Paediatric Vaccine Market Share by Players in 2020
Figure 22. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Vaccine as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Paediatric Vaccine Revenue in 2020
Figure 24. Global Paediatric Vaccine Revenue Market Share by Type (2016-2021)
Figure 25. Global Paediatric Vaccine Revenue Market Share by Type (2022-2027)
Figure 26. North America Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Paediatric Vaccine Market Share by Type (2016-2027)
Figure 28. North America Paediatric Vaccine Market Share by Application (2016-2027)
Figure 29. North America Paediatric Vaccine Market Share by Country (2016-2027)
Figure 30. United States Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Paediatric Vaccine Market Share by Type (2016-2027)
Figure 34. Europe Paediatric Vaccine Market Share by Application (2016-2027)
Figure 35. Europe Paediatric Vaccine Market Share by Country (2016-2027)
Figure 36. Germany Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Paediatric Vaccine Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Paediatric Vaccine Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Paediatric Vaccine Market Share by Region (2016-2027)
Figure 46. China Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Paediatric Vaccine Market Share by Type (2016-2027)
Figure 54. Latin America Paediatric Vaccine Market Share by Application (2016-2027)
Figure 55. Latin America Paediatric Vaccine Market Share by Country (2016-2027)
Figure 56. Mexico Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Paediatric Vaccine Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Paediatric Vaccine Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Paediatric Vaccine Market Share by Country (2016-2027)
Figure 62. Turkey Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Paediatric Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. GlaxoSmithCline Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 69. Abbott Laboratories Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 72. F. Hoffmann-La Roche Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 73. Novo Nordisk Revenue Growth Rate in Paediatric Vaccine Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---